Trials / Recruiting
RecruitingNCT06208514
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (estimated)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is intended to test whether a brief Zoom-based behavioral treatment can help adults with fibromyalgia (FM), Lupus, chronic pelvic pain, and chronic low back pain learn effective strategies for reducing pain, disability and other problems that can come with fibromyalgia, Lupus, chronic pelvic pain, and chronic low back pain (such as depression or anxiety).
Detailed description
This project was amended and approved by the University of Michigan Medical School Institutional Review Board. These changes include adding chronic pelvic pain and chronic low back pain participants on to the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Brief pain exposure therapy (BPET) | Participants will complete daily logs for 7-days pre-treatment baseline, along with 21 days during the intervention protocol (fibromyalgia participants only will complete the daily logs), and 7 for days post-treatment. Brief Pain Exposure Therapy will be given for 3 weeks, 1.5 hours per week, telehealth-based behavioral intervention for chronic pain. Session content will include pain neuroscience education, mindfulness meditation, and graded exposure techniques for improving tolerance of painful or feared activities. Participants will also be provided handouts and pre-recorded meditation and imagery scripts that participants can use to facilitate between-session practices. In addition, participants will complete surveys through-out the study. |
Timeline
- Start date
- 2024-03-04
- Primary completion
- 2026-04-01
- Completion
- 2026-07-01
- First posted
- 2024-01-17
- Last updated
- 2025-12-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06208514. Inclusion in this directory is not an endorsement.